Today, the life sciences industry faces increased regulation, tougher competition and more global challenges than ever before. Each of these issues directly affects the future of biopharmaceutical and medical device companies. Thorough preparation and careful navigation of the issues and opportunities are required to help open the doors to success down the road.
McDermott Will & Emery is pleased to present a series of complimentary webcasts focused on the corporate, commercial, regulatory and intellectual property (IP) opportunities and issues that life sciences companies, and those looking to buy or sell these companies, need to consider. Each webcast will cover one of today’s most pressing industry issues, and provide insight and practical advice on how to address the ever-changing landscape and prepare for success.
View archived webcasts and presentations
January 12, 2012: Successfully Managing False Claims Act Litigation: Controlling Costs and Internal Disruptions Materials
December 7 , 2011: Emerging Trends in IP as they Affect the Life Science Business Model Materials
November 9, 2011: Integrated Due Diligence for Life Sciences Companies; Enhancing and Preserving Valuation Materials
For more information, please contact McDermott Events.
CLE credit for the live presentation of this program is pending in the following states: California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states. Please note that in accordance with applicable state MCLE rules regarding attendance validation, each attendee seeking credit must log in to the webinar individually. Credit will not be granted for multiple attendees using one log in. Please be advised that CLE credit will not be approved for on demand/recorded viewings of this program in the states listed above. Attendees seeking credit in other states should consult their state CLE accrediting agency to determine whether self-study credit can be earned for on demand/recorded viewing of this program.